We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Greenwich LifeSciences Inc is a biopharmaceutical company that is developing GP2, an immunotherapy designed to prevent the recurrence of breast cancer following surgery. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variet... Greenwich LifeSciences Inc is a biopharmaceutical company that is developing GP2, an immunotherapy designed to prevent the recurrence of breast cancer following surgery. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in most breast cancers at low, intermediate, and high or overexpressor levels. Show more
STAFFORD, Texas, March 13, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical...
STAFFORD, Texas, March 12, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical...
STAFFORD, Texas, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical...
STAFFORD, Texas, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.24 | -1.86625194401 | 12.86 | 14.136 | 11.375 | 42260 | 12.70713992 | CS |
4 | -7.48 | -37.2139303483 | 20.1 | 20.55 | 11.375 | 37551 | 15.38771266 | CS |
12 | 3.89 | 44.5589919817 | 8.73 | 21.44 | 8 | 54568 | 14.45210142 | CS |
26 | 4.55 | 56.3816604709 | 8.07 | 21.44 | 7.58 | 34844 | 13.27688885 | CS |
52 | 1.64 | 14.9362477231 | 10.98 | 21.44 | 7.58 | 26571 | 12.17305224 | CS |
156 | -22.94 | -64.5106861642 | 35.56 | 48.96 | 6.8241 | 70514 | 18.39033252 | CS |
260 | 7.62 | 152.4 | 5 | 158.07 | 3.262 | 163083 | 36.96867769 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions